See this page online at: http://www.bioscienceworld.ca/2006Issue9
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
|
|
You Can't Win Them All
By Amber Lepage-Monette
Bill 102 comes close to satisfying stakeholders Making everyone happy with Bill 102 is proving tricky for the Ontario government, despite the widespread feeling that something needs to be done to fix the current system. |
|
|
|
The Transition Year
By Amber Lepage-Monette
Picking the lead candidates for Transition Therapeutics will be a decisive move for Tony Cruz, PhD. Transition Therapeutics Inc. isn't a company that sits back and lets things happen. This Toronto-based biopharmaceutical firm is all about action. |
|
|
|
Pharmacogenomics and Information-based Medicine
By Michael Hehenberger, PhD and Guido Roumans
The discipline of pharmacogenomics is aimed at discovering patterns in DNA, RNA, protein expression and biomarker data that correlate with disease risk, disease progression and drug response (clinical outcome)in an individual or a group of patients. |
|
|